Cytokinetics (CYTK) Share-based Compensation (2010 - 2026)
Cytokinetics' Share-based Compensation was $35.71 million in Q2 2026, up 29.7% from $27.54 million a year earlier and up 17.5% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cytokinetics' Share-based Compensation was $127.31 million through Jun 30, 2026, up 24.0% year-over-year; for FY2025, it was $112.29 million, up 14.8% from FY2024.
- Share-based Compensation has now increased for 11 consecutive years, with a five-year compound annual growth rate of 44.8% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $97.84 million in FY2024 (+35.8%), $72.07 million in FY2023 (+50.6%), $47.85 million in FY2022 (+78.3%) and $26.83 million in FY2021 (+52.3%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2010.
- Compared with a year earlier, Share-based Compensation has increased for 29 straight quarters, with growth averaging 23.4% over the last eight quarters.
- The year-over-year growth in Share-based Compensation has ranged between 9.0% (Q1 2025) and 101.1% (Q4 2022) over the last five years.
- Per Business Quant data, CYTK's Share-based Compensation in the three quarters before Q2 2026 was $30.39 million (Q1 2026), $30.51 million (Q4 2025) and $30.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Cytokinetics | 8.42 Bn | 4.59 Bn | 25.89 Mn | 35.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.71 Mn |
| Mar 31, 2026 | 30.39 Mn |
| Dec 31, 2025 | 30.51 Mn |
| Sep 30, 2025 | 30.70 Mn |
| Jun 30, 2025 | 27.54 Mn |
| Mar 31, 2025 | 23.55 Mn |
| Dec 31, 2024 | 26.25 Mn |
| Sep 30, 2024 | 25.36 Mn |
| Jun 30, 2024 | 24.62 Mn |
| Mar 31, 2024 | 21.61 Mn |
| Dec 31, 2023 | 19.49 Mn |
| Sep 30, 2023 | 18.72 Mn |
| Jun 30, 2023 | 18.67 Mn |
| Mar 31, 2023 | 15.20 Mn |
| Dec 31, 2022 | 13.45 Mn |
| Sep 30, 2022 | 13.20 Mn |
| Jun 30, 2022 | 12.20 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 6.71 Mn |
| Sep 30, 2021 | 7.77 Mn |
API Access
Cytokinetics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();